Physician Wealth Advisors’s Summit Therapeutics SMMT Stock Holding History

Physician Wealth Advisors’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510	Buy	+35	New	+$621	﹤0.01%	2118
2026 Q1	–	Sell	-55	Closed	-$962	–	2218
2025 Q4	$962	Hold	55	–	–	﹤0.01%	1649
2025 Q3	$1.14K	Hold	55	–	–	﹤0.01%	1503
2025 Q2	$1.17K	Buy	+55	New	+$1.25K	﹤0.01%	1290

Other funds holding SMMT

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HWM

Hohimer Wealth Management Seattle, Washington $1B AUM 33.02% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Physician Wealth Advisors's SMMT Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 35 shares worth $510. The stake represents ﹤0.01% of the portfolio and ranks #2118 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in SMMT as recently as Q4 2025.

Physician Wealth Advisors first reported a position in SMMT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.17K in Q2 2025. 47 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

Physician Wealth Advisors held 35 shares of Summit Therapeutics worth $510 as of Q2 2026.
Summit Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
Summit Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2118 holding.
Physician Wealth Advisors first reported a position in Summit Therapeutics in Q2 2025 and has held it in 4 quarters since.
Physician Wealth Advisors's Summit Therapeutics position peaked at $1.17K in Q2 2025.
47 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.